Intellectual Property India Publishes Patent Application for (r) -N-Ethyl-5-Fluoro-N-Isopropyl-2- ( (5- (2- (6- ( (2-Methoxyethyl) (methyl) Amino) -2-Methylhexan-3-Yl) -2, 6-Diazaspiro [3.4] Octan-6-Yl) -1, 2, 4-Triazin-6-Yl) Oxy) Benzamide, Formulations And Dosage Regimens Thereof, For Use In Treating Cancer

MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617059701 A) filed by Janssen Pharmaceutica Nv on May 11, 2026, for (r) -N-Ethyl-5-Fluoro-N-Isopropyl-2- ( (5- (2- (6- ( (2-Methoxyethyl) (methyl) Amino) -2-Methylhexan-3-Yl) -2, 6-Diazaspiro [3.4] Octan-6-Yl) -1, 2, 4-Triazin-6-Yl) Oxy) Benzamide, Formulations And Dosage Regimens Thereof, For Use In Treating Cancer.

Inventors include Ferrante, Lucille Angela; Packman, Kathryn Elizabeth; Cost, Carrye Rudolph; Curtis, Cecil Martin, Jr.; Daskalakis, Nikki; D'Souza, Amber Marie; Guttke, Christina Diane; Jacobs, Frank Bert Raf; Lomas, Oliver Christopher; Miller, Jonathan Jordan; Sanga, Madhu; Tucker, Trevor John; Van Beijsterveldt, Ludovicus Eugenie; Y...